Latest Breaking News On - Yannick tetzlaff - Page 1 : comparemela.com

Investegate |INVENTIVA Announcements | INVENTIVA: Description of the Share Repurchase Program Authorised by the Ordinary General Meeting of 19 May 2022

Investegate announcements from INVENTIVA, Description of the Share Repurchase Program Authorised by the Ordinary General Meeting of 19 May 2022

United statesYannick tetzlaffAude lepreuxPatricial bankBrunswick groupExchange commission onDescription of the share repurchase programShare repurchase program authorisedOrdinary general meetingFrench labor codeEuronext parisNasdaq global marketPrivate securities litigation reform actUniversal registration documentDes marchAnnual report

Investegate |INVENTIVA Announcements | INVENTIVA: Combined General Meeting of May 19, 2022 - Availability of the preparatory documents

Investegate announcements from INVENTIVA, Combined General Meeting of May 19, 2022 - Availability of the preparatory documents

New yorkUnited statesLe juraFrance generalYannick tetzlaffAude lepreuxPatricial bankBrunswick groupExchange commission onCombined general meetingLong island cityEuronext parisOceania le juraExchange commissionFrench commercial codeRue de dijon

INVENTIVA: Combined General Meeting of May 19, 2022 - Availability of the preparatory documents

Daix (France), Long Island City (New York, United States), April 28, 2022 - Inventiva (Euronext Paris and Nasdaq: IVA), a clinical-stage biopharmaceutical company focused on the development of oral small

New yorkUnited statesLe juraFrance generalYannick tetzlaffAude lepreuxPatricial bankBrunswick groupExchange commission onLong island cityEuronext parisCombined general meetingOceania le juraExchange commissionFrench commercial codeRue de dijon

INVENTIVA: The New England Journal of Medicine publishes the results of the NATIVE Phase IIb clinical trial with lanifibranor in NASH

In the Phase IIb NATIVE, lanifibranor met both the primary and key secondary endpoints, including NASH resolution with no worsening of fibrosis and improvement of liver fibrosis with no worsening of NASHNATIVE

New yorkUnited statesLyudmila matevaRohit loombaNicolas lanthierSven francqueStephena harrisonLuisa vonghiaMarie paule richardDiana stefanova petrovaManalf abdelmalekYannick tetzlaffMartine baudinArunj sanyalNaim alkhouriAude lepreux

Investegate |INVENTIVA Announcements | INVENTIVA: The New England Journal of Medicine publishes the results of the NATIVE Phase IIb clinical trial with lanifibranor in NASH

Investegate |INVENTIVA Announcements | INVENTIVA: The New England Journal of Medicine publishes the results of the NATIVE Phase IIb clinical trial with lanifibranor in NASH
investegate.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investegate.co.uk Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesLyudmila matevaRohit loombaNicolas lanthierSven francqueStephena harrisonLuisa vonghiaMarie paule richardDiana stefanova petrovaManalf abdelmalekYannick tetzlaffMartine baudinArunj sanyalNaim alkhouriAude lepreux